Quantitative analysis of CD133-positive cells has generally found them to be present at low levels in human gliomas, glioma neurosphere, and established glioma cell lines (6), consistent with the assumption that tumor stem cells are a rare cell population in solid tumors. The gene discussed is PROM1; the disease is central nervous system cancer.